Stockholm-based Technology Startup Sigrid Therapeutics Developing a Breakthrough Device to Lower Blood Sugar Levels, Closes Oversubscribed Round of $1.6m, Bringing Total Pre-launch Funding to $9m

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/30WX0ss
via IFTTT